There is still an unmet need for patients who progress on all current breast cancer treatment options. This new next-generation SERA compound has proven to have outstanding efficacy and tolerability, which is a strong indicator that SERA2 should produce... https://t.co/d3W7qwxBXs
Worried about how long #SERA2 (formerly #ErSO) will take to get to patients if another big pharma is brought in. Risking long retests/watering down.
Any chance of partnering with a
@cityofhope or @MDAndersonNews or efficient company like
@RNAoncology .
@SystemsOncology
One big question: what will @SystemsOncology present and will they get a partner out of this?
Systems Onc represents #SERA2 (formerly #ErSO).
It’s been a roller coaster. #ErSO held curative promise for #MBC back in 2020. Then went back to the lab for a toxicity fix.
Unless I missed it, @SystemsOncology is not on the formal #JPM23 conference agenda.
So #SERA2 (formerly #ErSO) is part of “private partnering meetings” only 🤔
If it truly has the
“…potential to create a real paradigm-shift” then it should be snapped up in minutes!!
Re: Systems Onc at #JPM23.
I cant figure this company out. But will say:
I talked privately in mid-December with a top SERA2 researcher.
This person did not expect a public presentation at #JPM23 saying that sharing something in the spring regarding their data was likely.
@SystemsOncology@ErSOActivism@LibbyMbc@UofIllinois
Are you any closer in having found a partnering big Pharma to bring SERA2 into clinic? First humans for this trial are desperately waiting.
https://t.co/4GPuA6xMgB
@Derya_@J_Immunol@jacksonlab Great to hear that. @Derya_ I wrote you an email and sent a message regarding your trials. I really would like to give it a go as I dont have any guns and dont wanna die just yet. I would appreciate if you reply to my email, so we can take it from there. Thx
#ESMOImmuno20 Virtual Congress: Watch Prof. Kevin Harrington, Scientific Co-Chair, give you powerful reasons to take part in this event. Remember that ESMO Members register for free 👉https://t.co/DwlOLi8kYa
Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined with nivolumab in patients with advanced solid tumors in the #ASCO22 poster session.
@Greeneyeman2@bodrumferibot Bodrum'dan Antalya'ya direk ucus opsiyonu yok. Peki kac alternatifim var benim? Sadece 1/otobus, Yunan Adasi yolcusunun kac alternatifi var? 1/ feribot. Cok alternatifli bir yolculuk bekliyormus iki yolcu grubunu da alternatifler arasinda secemiyormusuz havasi vermissiniz🙋♀️
@bodrumferibot Inanilir gibi degil! Bodrumdan&diger sahil beldelerinden Yunan Adalarina feribot var ama kendi ulkemin kiyilarina YOK! Niye Turk halkini Yunan Adalarina tatile gitmesi icin tesvik ediyorsunuz?Niye Bodrumdan feribotla Antalya'ya, Kemer'e, Fethiye'ye gidemiyorum?
@Greeneyeman2@bodrumferibot Yaz sezonunda ucak bileti bulmak neredeyse imkansiz, uc bes otobus firmasinin eline kalmis vatandas, ya da kendi araci varsa tonlarca benzin parasi harcayip seyahat ediyor. Yatirim yapilacak birsey de yok, Yunan adasina giden feribot, pekala Kemer'e, Antalya'ya, Fethiye'ye gider.
@bodrumferibot Bir tek Datca'ya ve Yunan Adalarina seyahat imkani var. Ne ara Antalya'ya, Kemer'e, Kas'a, Fethiye'ye, Kusadasina sefer baslatacaksiniz merak ediyorum. Yunan Adasi meraklisi degiliz🙋♀️
@kamilkoccom 16ATC425(10.30 seferi) Bodrum Antalya arasi seyir halindeyiz. Saat 15'e kadar tuvalet molasi verilmedi. Sehirici minibus gibi her yerde durarak yolcu alindi. Cok zaman kaybedildigi icin yiyecek molasi da verilmedi. Bugune kadar boyle vasat bir yolculuk gecirmemistim.